Immunovant Ownership | Who Owns Immunovant?
Immunovant Ownership Summary
Immunovant is owned by 54.48% institutional investors, 56.02% insiders. Fmr is the largest institutional shareholder, holding 7.95% of IMVT shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.36% of its assets in Immunovant shares.
IMVT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunovant | 54.48% | 56.02% | -10.50% |
| Sector | Healthcare Stocks | 245.53% | 12.09% | -157.62% |
| Industry | Biotech Stocks | 381.70% | 11.71% | -293.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 16.19M | 7.95% | $623.66M |
| Deep track capital, lp | 9.34M | 4.59% | $359.91M |
| Vanguard group | 7.78M | 4.48% | $197.75M |
| Blackrock | 4.92M | 3.56% | $129.79M |
| Blackrock funding, inc. /de | 7.18M | 3.53% | $276.68M |
| Farallon capital management | 5.80M | 2.85% | $223.67M |
| Baker bros. advisors lp | 5.44M | 2.67% | $209.42M |
| State street | 4.62M | 2.27% | $177.89M |
| Two seas capital lp | 4.61M | 2.24% | $155.82M |
| Morgan stanley | 4.53M | 2.23% | $174.73M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alpine global management | 1.38M | 8.61% | $52.98M |
| Deep track capital, lp | 9.34M | 5.24% | $359.91M |
| Superstring capital management lp | 208.37K | 5.07% | $8.03M |
| Tcg crossover management | 4.46M | 4.13% | $171.77M |
| Adar1 capital management | 2.33M | 4.11% | $89.80M |
| Silverarc capital management | 619.10K | 2.48% | $23.85M |
| Highvista strategies | 277.87K | 2.44% | $10.71M |
| Stempoint capital lp | 276.53K | 1.84% | $10.65M |
| Two seas capital lp | 4.61M | 1.80% | $155.82M |
| Tfg asset management gp | 255.93K | 1.55% | $9.86M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Farallon capital management | 5.80M | 1.03% | 4.26M |
| Price t rowe associates inc /md/ | 1.83M | 0.01% | 1.49M |
| Two seas capital lp | 4.61M | 1.80% | 1.46M |
| D. e. shaw | 1.24M | 0.02% | 1.24M |
| Vanguard group | 7.78M | 0.00% | 952.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 9.34M | 5.24% | -2.19M |
| Point72 asset management | - | - | -2.00M |
| Armistice capital | 1.74M | 0.82% | -1.83M |
| T. rowe price investment management | 2.22M | 0.06% | -1.39M |
| Paradigm biocapital advisors lp | - | - | -1.36M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| D. e. shaw | 1.24M | 0.02% | 1.24M | $47.80M |
| Sixth street partners management company | 680.59K | 0.00% | 680.59K | $26.22M |
| Balyasny asset management | 197.57K | 0.00% | 197.57K | $3.16M |
| Man group | 140.12K | 0.01% | 140.12K | $5.40M |
| Eam investors | 127.27K | 0.44% | 127.27K | $4.90M |
Sold Out
| Holder | Change |
|---|---|
| Dunhill financial | -1.00 |
| Reuter james wealth management | -1.00 |
| Physician wealth advisors | -1.00 |
| Capital performance advisors llp | -3.00 |
| Twin peaks wealth advisors | -3.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 236 | 4.42% | 110,973,566 | 0.34% | 54 | 1.48% | 112 | -19.42% | 81 | 97.56% |
| Mar 31, 2026 | 139 | -33.17% | 27,270,250 | -74.89% | 15 | 0.38% | 89 | -22.61% | 21 | -61.11% |
| Dec 31, 2025 | 165 | -16.24% | 62,414,346 | -34.42% | 35 | 1.16% | 93 | -4.12% | 40 | -23.08% |
| Sep 30, 2025 | 191 | 5.52% | 94,495,463 | -1.81% | 55 | 1.74% | 93 | -6.06% | 51 | 2.00% |
| Jun 30, 2025 | 178 | -15.64% | 96,201,301 | 3.59% | 56 | 1.41% | 96 | -25.58% | 50 | 19.05% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 6.94M | 3.36% | - |
| Fidelity Growth Compy Commingled Pl O | 4.45M | 3.04% | 196.00K |
| Fidelity Growth Company Fund | 5.09M | 2.47% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.60M | 1.27% | -14.64K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.60M | 1.27% | -14.64K |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.61M | 1.26% | -4.49K |
| Vanguard US Total Market Shares ETF | 2.12M | 1.25% | 2.26K |
| iShares Russell 2000 ETF | 2.25M | 1.09% | -10.80K |
| State Street® SPDR® S&P® Biotech ETF | 2.12M | 1.03% | -40.55K |
| Vanguard Small Cap Index | 1.89M | 0.91% | 218.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 02, 2026 | Venker Eric | Chief Executive Officer | Sell | $119.59K |
| Sep 23, 2026 | Van Tuyl Christopher | Chief Legal Officer | Sell | $103.48K |
| Aug 28, 2026 | Pande Atul | - | Sell | $64.91K |
| Aug 20, 2026 | Gloria Melanie | Chief Operating Officer | Sell | $134.95K |
| Jul 24, 2026 | Pande Atul | - | Sell | $59.70K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 15 |
| 2026 Q2 | - | 25 |
| 2026 Q1 | - | 7 |
| 2025 Q4 | 1 | 12 |
| 2025 Q3 | - | 4 |
IMVT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools